With regard to Health Canada’s drug review process for prescription drugs: (a) what percentage of approved prescription drugs currently on the market had a double-blind study conducted as part of their submissions to Health Canada; and (b) what percentage of prescription drugs approved in 2014 had a double-blind study conducted as part of their submissions to Health Canada?
In the House of Commons on June 5th, 2015. See this statement in context.